A detailed history of Terra Nova Asset Management LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Terra Nova Asset Management LLC holds 721 shares of VRTX stock, worth $340,888. This represents 0.25% of its overall portfolio holdings.

Number of Shares
721
Previous 721 -0.0%
Holding current value
$340,888
Previous $337,000 0.59%
% of portfolio
0.25%
Previous 0.28%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 15, 2024

BUY
$392.81 - $485.53 $25,139 - $31,073
64 Added 9.74%
721 $337,000
Q1 2024

Apr 25, 2024

BUY
$407.69 - $446.08 $30,576 - $33,456
75 Added 12.89%
657 $274,000
Q4 2023

Jan 18, 2024

BUY
$343.0 - $410.68 $199,626 - $239,015
582 New
582 $236,000

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $121B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Terra Nova Asset Management LLC Portfolio

Follow Terra Nova Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Terra Nova Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Terra Nova Asset Management LLC with notifications on news.